Pagliuca et al.'s [46] research showed that the generation of insulin-producing pancreatic β cells from stem cells in vitro would provide an unprecedented cell source for drug discovery and cell transplantation therapy in diabetes. The gene discussed is INS; the disease is diabetes mellitus.